cbapharma.com > cancer >problem of cancer

 

Problem Of Cancer

Cancer Facts

  • In the United States, 1 of every 4 deaths is from cancer
  • Cancer (1,500 deaths per day) is the second leading cause of death in the US, exceeded only by heart disease
  • The National Cancer Institute estimates that approximately 8.9 million Amercans with a history of cancer were alive.
  • Cancer is projected to pass heart disease as the leading cause of death
  • In 2003 about 1,334,100 new cancer cases were diagnosed. Approximately 180,000 people died of smoking related lung cancer.
  • In 2003 about 212,600 new cases of breast cancer were diagnosed. An estimated 40,000 of those cases lead to death.
  • Male smokers have a 20-fold relative risk in developing lung cancer.
  • In the US, 1 of 2 men and 1 of 3 women risk developing cancer in their lifetime

Cancer Treatments

The most common used methods for treating cancer include surgery, radiation,and chemotherapy.

At some point during their disease treatment:

  • 70% of all cancer patients will receive radiation therapy
  • 50% of all newly diagnosed cancer patients will receive chemotherapy
  • 4 million existing cancer patients are treated with chemotherapy in the United States today, with approximately 750,000 new cases being added annually. (2,055 new cases per day)

High Treatment Failure

  • Only 10% of patients treated with chemotherapy are cured.
  • approximately 90% of all cancer patients undergoing chemotherapy express or will develop multi-drug resistance

Causes of Treament Failure

Three causes of conventional cancer treatment failure include the following:

  • treatment related toxicities
  • multi-drug resistance to chemotherapy
  • tumor resistance to radiation

Multidrug Resistant Cancer

Cancer is a group of diseases that results from a variety of causes (i.e., toxic substances, nutrition, aging, cellular mutation, viruses, etc.) Although chemotherapy can show early improvement in the initial treatment of cancer patients, chemotherapy is no longer effective when the cancer cells become drug resistant. The subsequent reproduction of drug resistant cancer cells leads to untreatable cancer, resulting in the subsequent death of the patient. CBT-1® has been shown to be an effective treatment for multi-drug resistant cancer.

 

 

 
 

 

   

male
*Per 100,000, age-adjusted to the 1970 US standard population. Note: Due to changes in ICD coding, numerator information has changed over time. Rates for cancers of the liver, lung & bronchus, and colon & rectum are affected by these coding changes.

Source: US Mortality Public Use Data Tapes 1960-1996, US Mortality Volumes 1930-1959, National Center for Health Statistics, Centers for Disease Control and Prevention, 1999.

female
*Per 100,000, age-adjusted to the 1970 US standard population. †Uterus cancer death rates are for uterine cervix and uterine corpus combined. Note: Due to changes in ICD coding, numerator information has changed over time. Rates for cancers of the uterus, ovary, lung & bronchus, and colon & rectum are affected by these coding changes.

Source: US Mortality Public Use Data Tapes 1960-1996, US Mortality Volumes 1930-1959, National Center for Health Statistics, Centers for Disease Control and Prevention, 1999.

Graphs provided by American Cancer Society, Surveillance Research


 

 

  © CBA Pharma, Inc. blue Contact Us blue Search blue blue Terms and Conditions blue Site Map